CMG Pharmaceutical Co. Ltd (058820) — Cash Flow Quality Index
CMG Pharmaceutical Co. Ltd (058820) has a Cash Flow Quality Index of -0.71x as of September 2025. Operating cash flow of ₩-4.04 Billion is below net income of ₩5.73 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore CMG Pharmaceutical Co. Ltd (058820) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
CMG Pharmaceutical Co. Ltd Cash Flow Quality Index (2014–2024)
Historical Cash Flow Quality Index for CMG Pharmaceutical Co. Ltd across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see CMG Pharmaceutical Co. Ltd cash conversion from operations.
Annual Cash Flow Quality Index for CMG Pharmaceutical Co. Ltd (2014–2024)
Year-by-year earnings quality comparison for CMG Pharmaceutical Co. Ltd.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.11x | ₩290.09 Million | ₩2.69 Billion | ▼ -82.2% |
| 2023 | 0.61x | ₩3.91 Billion | ₩6.46 Billion | ▼ -65.9% |
| 2021 | 1.78x | ₩5.63 Billion | ₩3.17 Billion | ▼ -87.0% |
| 2020 | 13.69x | ₩2.94 Billion | ₩215.00 Million | ▲ +1379.9% |
| 2019 | 0.93x | ₩2.82 Billion | ₩3.05 Billion | ▲ +532.9% |
| 2018 | 0.15x | ₩886.78 Million | ₩6.07 Billion | ▼ -78.7% |
| 2017 | 0.69x | ₩1.95 Billion | ₩2.83 Billion | ▼ -48.6% |
| 2016 | 1.34x | ₩2.31 Billion | ₩1.73 Billion | ▼ -70.9% |
| 2014 | 4.59x | ₩724.89 Million | ₩158.04 Million | — |